IP Library › Granted Patent US 6,878,709
Granted Patent B2
US 6,878,709 · App. 10/335,789 · Granted Apr 12, 2005

3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,878,709
App. No.
10/335,789
Granted
Apr 12, 2005
Kind
B2
Abstract

Disclosed are compounds of the formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

Claims (4)

1. A compound selected from the group consisting of:

2. A compound selected from the group consisting of:

3. A compound selected from the group consisting of:

4. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier therefor.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2004
From: PHARMACOPEIA INC.
To: PHARMACOPEIA DRUG DISCOVERY
Reel/Frame 015144/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2004
From: CHAO, JIANPING
To: SCHERING CORPORATION
Reel/Frame 014946/0929 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2004
From: BALDWIN, JOHN J.; MERRITT, J. ROBERT
To: PHARMACOPEIA, INC.
Reel/Frame 014946/0972 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2004
From: LI, GE
To: PHARMACOPEIA, INC.
Reel/Frame 014947/0058 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2004
From: TAVERAS, ARTHUR G.; DWYER, MICHAEL; CHAO, JIANHUA; YU, YOUNONG
To: SCHERING CORPORATION
Reel/Frame 014947/0080 →